| Patent | Date |
|---|
Selective Local Inhibition Of Tnfr1-mediated Functions At The Site Of Antigen/allergen Presentation
App 20220273791 - Bredehorst; Reinhard ; et al. | 2022-09-01 |
Induction of antigen-specific tolerance by peripheral phagocytosis
Grant 11,065,330 - Bredehorst , et al. July 20, 2 | 2021-07-20 |
Selective Local Inhibition Of Tnfr1-mediated Functions At The Site Of Antigen/allergen Presentation
App 20190282692 - Bredehorst; Reinhard ; et al. | 2019-09-19 |
Controlled activation of complement components for use as endogenous adjuvant
Grant 10,238,735 - Bredehorst , et al. | 2019-03-26 |
Matrix-embedded Tolerance-promoting Adjuvants For Subcutaneous Immunotherapy
App 20180085452 - BREDEHORST; Reinhard ; et al. | 2018-03-29 |
Selective Local Inhibition Of Tnfr1-mediated Functions At The Site Of Antigen/allergen Presentation
App 20170072048 - Bredehorst; Reinhard ; et al. | 2017-03-16 |
Antigen-specific Immunotherapy Using Tolerizing Liposomes
App 20160338955 - Bredehorst; Reinhard ; et al. | 2016-11-24 |
Induction of Antigen-Specific Tolerance by Peripheral Phagocytosis
App 20150283231 - BREDEHORST; Reinhard ; et al. | 2015-10-08 |
Selective Local Inhibition Of Tnfr1-mediated Functions At The Site Of Antigen/allergen Presentation
App 20140178474 - Bredehorst; Reinhard ; et al. | 2014-06-26 |
Method for determining an unknown PNA sequence and uses thereof
App 20140163200 - Bredehorst; Reinhard ; et al. | 2014-06-12 |
Controlled Activation Of Complement Components For Use As Endogenous Adjuvant
App 20130337045 - Bredehorst; Reinhard ; et al. | 2013-12-19 |
Modulation Of Effector T Cell Responses By Local Depletion Of Complement Component C3
App 20130337044 - Bredehorst; Reinhard ; et al. | 2013-12-19 |
Complement depletion using recombinant human C-3 derivatives
Grant 8,119,769 - Kolln , et al. February 21, 2 | 2012-02-21 |
Chimera of human IgE receptor .alpha.-chain and avian constant immuno-globulin domains for the determination of serum IgE
Grant 7,897,153 - Braren , et al. March 1, 2 | 2011-03-01 |
Bivalent IgY antibody constructs for diagnostic and therapeutic applications
Grant 7,696,323 - Bredehorst , et al. April 13, 2 | 2010-04-13 |
Method for determining an unknown PNA sequence and uses thereof
App 20100081801 - Bredehorst; Reinhard ; et al. | 2010-04-01 |
Complement Depletion Using Recombinant Human C-3 Derivatives
App 20090270324 - KOLLN; JOHANNA ; et al. | 2009-10-29 |
Complement depletion using recombinant human C3-derivatives
Grant 7,553,931 - Kolln , et al. June 30, 2 | 2009-06-30 |
Bivalent IgY antibody constructs for diagnostic and therapeutic applications
App 20070141049 - Bredehorst; Reinhard ; et al. | 2007-06-21 |
Sensor arrangement with electrically controllable arrays
Grant 7,208,077 - Albers , et al. April 24, 2 | 2007-04-24 |
Method for producing detection systems with planar arrays
Grant 6,881,379 - Bredehorst , et al. April 19, 2 | 2005-04-19 |
Complement depletion using recombinant human C3-derivatives
App 20050079585 - Kolln, Johanna ; et al. | 2005-04-14 |
Recombinant proCVF
Grant 6,607,897 - Vogel , et al. August 19, 2 | 2003-08-19 |
Recombinant proCVF
App 20020103346 - Vogel, Carl-Wilhelm ; et al. | 2002-08-01 |
In vivo binding pair pretargeting
Grant 5,807,534 - Pomato , et al. September 15, 1 | 1998-09-15 |
High yield preparation of dimeric to decameric chitin oligomers
Grant 5,705,634 - Bredehorst , et al. January 6, 1 | 1998-01-06 |
Site specific in vivo activation of therapeutic drugs
Grant 5,433,955 - Bredehorst , et al. July 18, 1 | 1995-07-18 |
S-(2-thiopyridyl)-L-cysteine, a heterobifunctional crosslinking reagent
Grant 5,157,123 - Zara , et al. October 20, 1 | 1992-10-20 |
Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent
Grant 5,077,210 - Eigler , et al. December 31, 1 | 1991-12-31 |
| 